Nearly 1 in 6 pediatric patients who started a glucagon-like peptide-1 receptor agonist (GLP-1 RA) were diagnosed with a ...

Scientists have inched a step closer to developing a first-of-its-kind drug to treat lymphedema, a chronic swelling condition ...

While it’s estimated that one in three survivors experience cognitive problems such as difficulty with attention and memory, ...

Meditech’s Traverse Exchange network connects more than 800 facilities across 200 organizations, providing access to health information for more than 43 ...

For October's Health Literacy Month, Dr. Tiffany Hendricks and registered nurse and diabetes educator Yvette Oxford joined ...

Hone Health reports a September 2026 FDA workshop on testosterone for menopausal women, exploring its benefits for sexual ...

Although artificial intelligence has quickly become integrated into our daily lives, Americans say they’re becoming increasingly concerned about their health data, making them less likely to use it ...

The drug, the first of its kind to target three metabolic receptors (GLP-1, GIP, and glucagon), is nearing the end of clinical trials and is expected to be submitted to the FDA for approval early ...

Office of the Governor. The Hawaiʻi Department of Health is continuing to coordinate with the National Park Service and other ...

New data from Motive Medical Intelligence show that many clinicians skip regular cholesterol checks in cardiovascular care.

Health care patients would have to be told when a facility is using artificial intelligence to make clinical decisions under ...

Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data ...